Yifeng
Yifeng Pharmacy Chain Co., Ltd. engages in pharmaceutical retail business in China.
Yifeng, founded in June, 2008 and headquartered in Changde, is a national large-scale pharmaceutical retail chain enterprise. The founder is Gao Yi. Listed on the SSE on February 17, 2015, the company's major shareholders are Ningbo Meishan Bonded Port Zone Jikang Enterprise Management Partnership (LP), Hong Kong Central Clearing Co., Ltd. and Gao Yi. Rivals that have direct and indirect competition with Yifeng include 111 Group, JD health, Glaxo Smith Kline, Pfizer, etc.
Is the U.S. TikTok the biggest opportunity for going global in 2024?
TikTok, a short-video social platform under ByteDance, made its debut in May 2017 and has since become a global phenomenon with over 1 billion active users worldwide.
Jan 16, 2024 06:05 AM
Research
Consumer Staples, Healthcare, TechnologyWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Financials, Automotive, Consumer StaplesTech for Global, Globalization Footprints of the Established and the New
Pharmaceutical business concept stocks quickly rose the first pharmaceutical trading limit
Rice ball takeout has officially entered the Australian market, and high-quality takeout services have captured overseas food
Robosen completed round B and round B + financing of nearly US $100 million
The new brand Hutou Bureau has signed a strategic cooperation with tmall. In the future, heavy new products will be launched in tmall
Happy cake has completed a new round of financing of RMB 100 million, led by Asian business capital and followed by Chunjian capital. The listing plan will be launched in the future
Weixiaofan, a new digital fast food brand, has completed a round of financing of nearly 100 million yuan, with Tiantu's exclusive investment
Yuntianhua: the shareholder completed the reduction of 2% of the shares with the investment of Yuntianhua
Yifeng: Xiao Zaixiang, the Vice President, Intends to Sell Shares